Amman Bradford K. 4
4 · Vivos Therapeutics, Inc. · Filed Mar 17, 2021
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Award
Stock Option
2021-03-12$7.50/sh+100,000$750,000→ 200,001 totalExercise: $7.50Exp: 2026-03-12→ Common Stock (100,000 underlying)
Holdings
- 1,000
Common Stock
Footnotes (1)
- [F1]100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.